{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np \n",
    "import pandas as pd \n",
    "from matplotlib import pyplot as plt \n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Combination Ratio \n",
    "\n",
    " > \"The efficacy of each combination relative to its respective single agents was quantified with combination ratio (CR) values, defined as the IC50 or area under the fitted dose–response curve for the combination divided by the lowest IC50 or\n",
    "area under the curve (AUC) value for either single agent. By this metric, a CR value of less than 1 indicates the drug combination is more effective than either single agent. We derived these CR values because of known limitations of applying conventional synergy calculations when one or more of the single agents is completely ineffective on particular samples (25).\" [1]\n",
    "\n",
    "1. Kurtz SE, Eide CA, Kaempf A, Khanna V, Savage SL, Rofelty A, et al. Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies. Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7554–63. \n",
    "\n",
    "25. Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58: 621–681.\n",
    "\n",
    "--- \n",
    "\n",
    "We will interpret this as the following: \n",
    "\n",
    "$$  CR = \\frac{AUC_{combination}}{min(AUC_{drug1}, AUC_{drug2})} $$ "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Load data "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "JQ1;BEZ235\n",
      "Lucitanib\n",
      "Resveratrol\n",
      "Pelitinib (EKB-569)\n",
      "Bicalutamide\n",
      "Methotrexate\n",
      "Midostaurin (PKC-412)\n",
      "Tamatinib/R406\n",
      "Bosutinib\n",
      "PI-103\n",
      "Glycyrrhizin\n",
      "Luteolin (direct interaction)\n",
      "GSK-690693\n",
      "Ibrutinib\n",
      "Dasatinib;Gefitinib\n",
      "Sorafenib\n",
      "Rosmarinic acid\n",
      "Rapamycin\n",
      "Vismodegib\n",
      "PP242\n",
      "Alectinib\n",
      "MK-2206\n",
      "Ruxolitinib;Gefitinib\n",
      "Flavopiridol\n",
      "Indirubin\n",
      "PF-533228\n",
      "Licochalcone A (from licorice)\n",
      "17-AAG (Tanespimycin)\n",
      "Emodin\n",
      "Baicalin\n",
      "NVP-TAE-684\n",
      "Panobinostat\n",
      "PP242;Gefitinib\n",
      "Fulvestrant\n",
      "SCH-772984\n",
      "MLN120B\n",
      "Ixabepilone\n",
      "Canertinib (CI-1033)\n",
      "Selumetinib (AZD6244)\n",
      "I-BET 762;Gefitinib\n",
      "NF-kB (QNZ)\n",
      "Letrozole\n",
      "Coumarin\n",
      "Afatinib;Gefitinib\n",
      "Foretinib (XL-880)\n",
      "Elesclomol\n",
      "Vemurafenib\n",
      "I-BET 762;BEZ235\n",
      "Ponatinib\n",
      "Sunitinib (1mM)\n",
      "Curcumin\n",
      "PF-562271\n",
      "STO609\n",
      "Lenvatinib\n",
      "Entrectinib\n",
      "Ethyl Gallate\n",
      "GDC-0941\n",
      "Dovitinib\n",
      "BI-2536\n",
      "TP-0903\n",
      "Belinostat\n",
      "INK-128\n",
      "Trametinib;Gefitinib\n",
      "Bosutinib;Gefitinib\n",
      "Pazopanib\n",
      "AZD4547\n",
      "Pomalidomide\n",
      "Idelasib (GS-1101)\n",
      "(+)-Anwulignan (macelignan)\n",
      "Staurosporin\n",
      "Tozasertib (VX-680)\n",
      "Hesperidin\n",
      "Esculetin\n",
      "Selinexor\n",
      "Infigratinib/NVPBGJ398\n",
      "BMX-IN-1\n",
      "Dasatinib (1mM)\n",
      "Bortezomib (Velcade)\n",
      "Nilotinib\n",
      "Enzalutamide\n",
      "Caffeic acid (oral cancer research)\n",
      "JQ1;Gefitinib\n",
      "BMS-387032 (SNS-032)\n",
      "Axitinib\n",
      "Thalidomide\n",
      "Vandetanib\n",
      "Oleic acid\n",
      "A-674563\n",
      "Lapatinib\n",
      "Apocynin (vanillin)\n",
      "AT-7519\n",
      "Axitinib;Gefitinib\n",
      "Crizotinib;Gefitinib\n",
      "JQ1\n",
      "Andrographolide (structurally similar to quercetin)\n",
      "Cerdulatinib\n",
      "Romidepsin\n",
      "Gilteritinib\n",
      "Anastrazole\n",
      "JNJ-28312141\n",
      "Genistein\n",
      "Abscisic acid\n",
      "Alisertib (MLN-8237)\n",
      "Ruxolitinib\n",
      "TAK-659\n",
      "Lestaurtinib (CEP-701)\n",
      "Vorinostat\n",
      "Lenalidomide\n",
      "NVP-ADW742\n",
      "Piceatannol (resveratrol metabolite, maybe more potent)\n",
      "Echinatin\n",
      "YM-155\n",
      "Herniarin (derivative of coumarin)\n",
      "Stevioside\n",
      "Pemetrexed\n",
      "Taselisib (GDC-0032)\n",
      "GSK-1838705A\n",
      "Ceritinib;Gefitinib\n",
      "Imatinib\n",
      "Saracatinib\n",
      "I-BET 762\n",
      "Neratinib (HKI-272)\n",
      "Ginsenoside Rb2\n",
      "Crizotinib\n",
      "MGCD-265\n",
      "Erlotinib\n",
      "Vandetanib;GDC-0941\n",
      "Lapatinib;Ditosylate;Axitinib\n",
      "Sunitinib;Malate;Axitinib\n",
      "Gefitinib;Sorafenib;Tosylate\n",
      "Lapatinib;Ditosylate;Belinostat\n",
      "Erlotinib;Hydrochloride;BEZ235\n",
      "Sunitinib;Malate;Romidepsin\n",
      "Lapatinib;Ditosylate;GDC-0941\n",
      "Gefitinib;Vorinostat\n",
      "Sunitinib;Malate;Belinostat\n",
      "Erlotinib;Hydrochloride;Axitinib\n",
      "VOLASERTIB x\n",
      "Vandetanib;Imatinib;Mesylate\n",
      "Canertinib (CI-1033);PI-103\n",
      "Lapatinib;Ditosylate;Vorinostat\n",
      "Gefitinib;Fulvestrant\n",
      "Vandetanib;PI-103\n",
      "Sunitinib;Malate;Pazopanib;Hydrochloride\n",
      "Erlotinib;Hydrochloride;Idelasib (GS-1101)\n",
      "Gefitinib;PI-103\n",
      "AZD2014 x\n",
      "Vandetanib;Belinostat\n",
      "Sunitinib;Erlotinib;Hydrochloride;Malate\n",
      "MLN7243 x (1mM)\n",
      "Vandetanib;Afatinib;Dimaleate\n",
      "Gefitinib;Pemetrexed;Disodium\n",
      "Lapatinib;Ditosylate;Fulvestrant\n",
      "Sunitinib;Malate;Vorinostat\n",
      "Sunitinib;Malate;Bosutinib\n",
      "Erlotinib;Hydrochloride;Crizotinib\n",
      "Lapatinib;Ditosylate;Pemetrexed Disodium\n",
      "Erlotinib;Hydrochloride;Romidepsin\n",
      "Vandetanib;Idelasib (GS-1101)\n",
      "Lapatinib;Ditosylate;Idelasib (GS-1101)\n",
      "Erlotinib;Hydrochloride;Bosutinib\n",
      "Erlotinib;Hydrochloride;Belinostat\n",
      "Vandetanib;Ruxolitinib;Phosphate\n",
      "Dasatinib;Lapatinib;Ditosylate\n",
      "Gefitinib;Imatinib;Mesylate\n",
      "Sunitinib;Malate;Ruxolitinib;Phosphate\n",
      "Erlotinib;Hydrochloride;Imatinib;Mesylate\n",
      "Gefitinib;Pazopanib;Hydrochloride\n",
      "Sunitinib;Malate;Afatinib;Dimaleate\n",
      "Gefitinib;Vandetanib\n",
      "Lapatinib;Ditosylate;Romidepsin\n",
      "Vandetanib;Axitinib\n",
      "Erlotinib;Hydrochloride;Vorinostat\n",
      "Sunitinib;Malate;Dasatinib\n",
      "Vandetanib;Fulvestrant\n",
      "Gefitinib;GDC-0941\n",
      "Sunitinib;Malate;Pemetrexed Disodium\n",
      "Lapatinib;Ditosylate;Imatinib;Mesylate\n",
      "Vandetanib;Taselisib (GDC-0032)\n",
      "Erlotinib;Hydrochloride;Pemetrexed Disodium\n",
      "Vandetanib;BEZ235\n",
      "Gefitinib;Belinostat\n",
      "Gefitinib;Romidepsin\n",
      "APTO-253 x\n",
      "Erlotinib;Hydrochloride;Panobinostat\n",
      "Sunitinib;Malate;Fulvestrant\n",
      "Sunitinib;Lapatinib;Ditosylate;Malate\n",
      "Erlotinib;Hydrochloride;Taselisib (GDC-0032)\n",
      "Lapatinib;Ditosylate;Afatinib;Dimaleate\n",
      "Lapatinib;Ditosylate;BEZ235\n",
      "Erlotinib;Hydrochloride;Ponatinib;Hydrochloride\n",
      "Gefitinib;Panobinostat\n",
      "Erlotinib;Hydrochloride;Fulvestrant\n",
      "Lapatinib;Ditosylate;Ruxolitinib;Phosphate\n",
      "Gefitinib;Ponatinib;Hydrochloride\n",
      "Lapatinib;Ditosylate;Ponatinib;Hydrochloride\n",
      "Vandetanib;Ponatinib;Hydrochloride\n",
      "Sunitinib;Malate;Ponatinib;Hydrochloride\n",
      "Gefitinib;Taselisib (GDC-0032)\n",
      "Erlotinib;Hydrochloride;Nilotinib\n",
      "Vandetanib;Pemetrexed Disodium\n",
      "Gefitinib;Erlotinib;Hydrochloride\n",
      "Erlotinib;Hydrochloride;Ruxolitinib;Phosphate\n",
      "Vandetanib;Vorinostat\n",
      "Sunitinib;Gefitinib;Malate\n",
      "Lapatinib;Ditosylate;Taselisib (GDC-0032)\n",
      "Gefitinib;Nilotinib\n",
      "Vandetanib;Erlotinib;Hydrochloride\n",
      "Sunitinib;Malate;Imatinib;Mesylate\n",
      "Erlotinib;Hydrochloride;Afatinib;Dimaleate\n",
      "Lapatinib;Ditosylate;Pazopanib;Hydrochloride\n",
      "Vandetanib;Dasatinib\n",
      "Erlotinib;Hydrochloride;GDC-0941\n",
      "Gefitinib;Lapatinib;Ditosylate\n",
      "Lapatinib;Ditosylate;Bosutinib\n",
      "Dasatinib;Erlotinib;Hydrochloride\n",
      "IMR 1\n",
      "Sunitinib;Malate;Sorafenib;Tosylate\n",
      "Lapatinib;Ditosylate;PI-103\n",
      "Sorafenib;Erlotinib;Hydrochloride;Tosylate\n",
      "Gefitinib;Idelasib (GS-1101)\n",
      "Vandetanib (5mM)\n",
      "Erlotinib;Hydrochloride;Pazopanib;Hydrochloride\n",
      "Lapatinib;Ditosylate;Sorafenib;Tosylate\n",
      "BS-181-HCI x (4.54mM)\n",
      "Erlotinib;Hydrochloride;PI-103\n",
      "LY3039478\n",
      "Gefitinib;IMR 1\n",
      "Gefitinib;LY3039478\n",
      "Larotrectinib\n",
      "TAK-733\n",
      "Stauprimide\n",
      "SGX-523\n",
      "Yellow\n"
     ]
    }
   ],
   "source": [
    "data = pd.read_csv('../output/HNSCC_cleaned_data.csv')\n",
    "\n",
    "print( '\\n'.join( data.inhibitor.unique() ) )"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Process one combination "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_combination_ratio(comb, lab_id, df, verbose=True): \n",
    "    '''\n",
    "    summ \n",
    "    \n",
    "    input\n",
    "        comb <str> should be in form: \"drug1;drug2\"; There should not be more than 2 drugs in combination. \n",
    "        data <dataframe> \n",
    "        \n",
    "    output \n",
    "        combination ratio <float> \n",
    "    '''\n",
    "    \n",
    "    data = df[df.lab_id == lab_id]\n",
    "    \n",
    "    assert comb.count(';') == 1, f'expected only 2 drugs, received {comb.count(\";\")}: \\n\\t {comb}'\n",
    "    \n",
    "    drug1, drug2 = comb.strip().split(';')\n",
    "    \n",
    "    if verbose: print('calculating CR for:', (drug1, drug2))\n",
    "        \n",
    "    comb_df = data[data.inhibitor == comb]\n",
    "    drug1_df = data[data.inhibitor == drug1]\n",
    "    drug2_df = data[data.inhibitor == drug2]\n",
    "    \n",
    "    #print(comb_df)\n",
    "    #print(drug1_df)\n",
    "    #print(drug2_df)\n",
    "    \n",
    "    assert comb_df.shape[0] == 1, f'combination data expected one entry, but got {comb_df.shape[0]}'\n",
    "    assert drug1_df.shape[0] == 1, f'{drug1} data expected one entry, but got {drug1_df.shape[0]}'\n",
    "    assert drug2_df.shape[0] == 1, f'{drug2} data expected one entry, but got {drug2_df.shape[0]}'\n",
    "    \n",
    "    comb_AUC = float( comb_df['AUC'].values[0] )\n",
    "    drug1_AUC = float( drug1_df['AUC'].values[0] )\n",
    "    drug2_AUC = float( drug2_df['AUC'].values[0] )\n",
    "    \n",
    "    CR = comb_AUC / min(drug1_AUC, drug2_AUC)\n",
    "    \n",
    "    return CR "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Test example"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "calculating CR for: ('Vandetanib', 'GDC-0941')\n",
      "Vandetanib;GDC-0941 CR value: 1.1173498779392539\n"
     ]
    }
   ],
   "source": [
    "comb = \"Vandetanib;GDC-0941\"\n",
    "labid = 10004\n",
    "\n",
    "CR = get_combination_ratio(comb, labid, data)\n",
    "\n",
    "print(f'{comb} CR value: {CR}')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Try all "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "in progress... 95.00%\t\t\t\r"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>lab_id</th>\n",
       "      <th>inhibitor</th>\n",
       "      <th>CR</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10004</td>\n",
       "      <td>Vandetanib;GDC-0941</td>\n",
       "      <td>1.117350</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10004</td>\n",
       "      <td>Canertinib (CI-1033);PI-103</td>\n",
       "      <td>0.400734</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10004</td>\n",
       "      <td>Vandetanib;PI-103</td>\n",
       "      <td>0.983893</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10004</td>\n",
       "      <td>Vandetanib;Belinostat</td>\n",
       "      <td>0.704335</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>10004</td>\n",
       "      <td>Vandetanib;Idelasib (GS-1101)</td>\n",
       "      <td>0.729440</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   lab_id                      inhibitor        CR\n",
       "0   10004            Vandetanib;GDC-0941  1.117350\n",
       "1   10004    Canertinib (CI-1033);PI-103  0.400734\n",
       "2   10004              Vandetanib;PI-103  0.983893\n",
       "3   10004          Vandetanib;Belinostat  0.704335\n",
       "4   10004  Vandetanib;Idelasib (GS-1101)  0.729440"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "combinations = data.inhibitor.str.contains(';')\n",
    "\n",
    "res = {'lab_id':[], 'inhibitor':[], 'CR':[]}\n",
    "\n",
    "npat = data.lab_id.unique().shape[0]\n",
    "failed_combinations = [] \n",
    "\n",
    "for i, labid in enumerate( data.lab_id.unique() ): \n",
    "    print(f'in progress... {i/npat * 100 :.2f}%', end='\\t\\t\\t\\r')\n",
    "    pat = data[data.lab_id == labid]\n",
    "    for comb in pat[pat.inhibitor.str.contains(';')].inhibitor.unique(): \n",
    "        try: \n",
    "            CR = get_combination_ratio(comb, labid, pat, verbose=False)\n",
    "            res['lab_id'].append(labid)\n",
    "            res['inhibitor'].append(comb)\n",
    "            res['CR'].append(CR)\n",
    "        except AssertionError: \n",
    "            failed_combinations.append(comb)\n",
    "        \n",
    "res = pd.DataFrame(res)\n",
    "res.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Distribution of Combination Ratio values "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure()\n",
    "plt.hist(res.CR)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Synergistic combinations \n",
    "\n",
    "We'll use less than `0.9` to denote synergy "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>lab_id</th>\n",
       "      <th>inhibitor</th>\n",
       "      <th>CR</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10004</td>\n",
       "      <td>Canertinib (CI-1033);PI-103</td>\n",
       "      <td>0.400734</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10004</td>\n",
       "      <td>Vandetanib;Belinostat</td>\n",
       "      <td>0.704335</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>10004</td>\n",
       "      <td>Vandetanib;Idelasib (GS-1101)</td>\n",
       "      <td>0.729440</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>10004</td>\n",
       "      <td>Vandetanib;Taselisib (GDC-0032)</td>\n",
       "      <td>0.752586</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>10021</td>\n",
       "      <td>Canertinib (CI-1033);PI-103</td>\n",
       "      <td>0.651554</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    lab_id                        inhibitor        CR\n",
       "1    10004      Canertinib (CI-1033);PI-103  0.400734\n",
       "3    10004            Vandetanib;Belinostat  0.704335\n",
       "4    10004    Vandetanib;Idelasib (GS-1101)  0.729440\n",
       "7    10004  Vandetanib;Taselisib (GDC-0032)  0.752586\n",
       "10   10021      Canertinib (CI-1033);PI-103  0.651554"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "syn = res[res.CR <= 0.9]\n",
    "syn.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 504x504 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "cnt = syn.groupby('inhibitor').count()['CR'].reset_index()\n",
    "\n",
    "f,ax = plt.subplots(1,1, figsize=(7,7))\n",
    "ax.bar(cnt.inhibitor, cnt.CR)\n",
    "ax.set_xticklabels(cnt.inhibitor, rotation=40, ha='right')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Canertinib (CI-1033);PI-103\n",
    "\n",
    "Almost all patients were synergistic to this one. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "can_pi = res[res.inhibitor == 'Canertinib (CI-1033);PI-103']\n",
    "\n",
    "plt.figure()\n",
    "plt.hist(can_pi.CR, bins=np.linspace(0,1,10))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Vandetanib;Taselisib (GDC-0032)\n",
    "\n",
    "Just another example to examine"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "van_tas = res[res.inhibitor == 'Vandetanib;Taselisib (GDC-0032)']\n",
    "\n",
    "plt.figure()\n",
    "plt.hist(van_tas.CR, bins=np.linspace(0,1,20))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Plot CR distributions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "f,axes = plt.subplots(3,3, figsize=(8,8))\n",
    "\n",
    "for ax, comb in zip(axes.flat, res.combinations.inhibitor.unique()): \n",
    "    df = res[res.inhibitor == comb] \n",
    "    ax.hist(df.CR, bins=np.linspace(0,1,20))\n",
    "    ax.set_title(comb)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.5"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
